VSIG4 and interstitial lung disease: We selected 6 candidates, including SPP1, SAA1, KNG1, F11, F13A1, and VSIG4 for validation in an independent cohort comprised of 20 RP-ILD patients, 20 non-RP patients, and 20 HC using the ELISA test.